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Abstract
Background
Routine surveillance is required to monitor the performance of tuberculosis diagnostic pro-
gramme and is essential for the rapid detection of drug resistance. The main objective of
this study was to explore the effectiveness and stakeholder perception of the current routine
surveillance system for previously treated tuberculosis cases in Tanzania with a view to
identify interventions to improve and accelerate positive patient outcomes.
Methods
A study using quantitative and qualitative methods of data collection including in-depth
interviews and focus group discussions with health care service providers was conducted in
four regions. Quantitative data were extracted from the routine databases to assess
performance.
Results
Quantitative findings from 2011 to 2013 showed 2,750 specimens from previously treated
TB cases were received at the reference laboratory. The number increased year on year,
but even in the most recent year was only 61% of that expected. The median and interquar-
tile range of turnaround time in days from specimen reception to results reported for smear
microscopy, culture and drug susceptibility testing were 1(1, 1), 61(43, 71) and 129(72, 170)
respectively. Contaminated specimens were reported in 3.6% of cases. The qualitative anal-
ysis showed the system of sending specimens using postal services was seen to be efficient
by participants. However, there were many challenges and significant delays in specimens
reaching the reference laboratory associated with lack of funds to transfer specimens, weak
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form completion, inadequate training and poor supervision. These all adversely affected the
implementation of the routine surveillance system.
Conclusions
Many issues limit the effectiveness of the routine surveillance system in Tanzania. Priority
areas for strengthening are; specimen transportation, supervision and availability of com-
modities. A pilot study of a revised routine surveillance system that takes into account the
observations from this study alongside improved access to drug susceptibility testing using
Xpert MTB/RIF should be considered.
Introduction
Tuberculosis (TB) remains a major global health problem alongside Human Immunodefi-
ciency Virus (HIV) /Acquired Immune Deficiency Syndrome (AIDS) as a leading cause of
death [1]. Global TB control efforts have made progress in the past decade, however despite
this in 2016 the World Health Organization estimated there were 10.4 million incident cases of
TB and 1.4. million deaths from TB. 11% of the incident cases were people living with HIV.
WHO estimates 4 million were cases were undiagnosed. [1]. Drug-resistant TB is a threat
across the globe with estimated incidence of 480,000 Multidrug Resistant TB (MDR-TB) cases,
of which 9.5% were Extensively Drug Resistant TB (XDR-TB). [1]. In the same year only 30%
of the 3.4 million new bacteriologically confirmed and previously treated TB cases notified,
were reported to have been tested for resistance to Rifampicin (one of the key drugs used to
treat TB in the standard TB regimen).[1]. The development of XDR-TB has added a new
dimension to the threat of the TB epidemic and highlights the inadequate resources available
in many settings. [2]. The need for reliable drug-susceptibility testing and an appropriate
shorter course MDR-TB treatment regimen has increased with the growth in incidence in
many parts of the world. [3]. Application of molecular methods during the last decade has
greatly changed the understanding of drug resistance in TB. [4]. In 2010 the World Health
Organisation (WHO) endorsed the use of Xpert MTB/RIF assay in low and middle-income
countries. [5]. Tanzania is among the 30 countries with the highest TB burden worldwide
according to the WHO. [1]. In Tanzania 63,151 TB cases were notified in 2015 of these 60,563
were new cases and 1,580 were previously treated TB cases. [1]. The MDR-TB rate estimation
from the 2006 Drug Resistance Survey (DRS) was 1.1% and 3.1% in new and previously treated
TB cases respectively. [6]. The WHO recent estimates are 1.3% for new and 4.7% of previously
treated cases. [7]. The WHO recommends using more rapid and sensitive diagnostic methods
for drug resistance testing. [8]. At the time of the study Acid Fast Bacilli smear microscopy was
the main TB diagnostic tool in the country and there were 735 TB centres. There were two
Zonal TB culture laboratories and only one standalone Central TB Reference Laboratory with
capacity to routinely perform culture and drug susceptibility testing for patient monitoring
and drug resistant identification. [9]. The National TB and Leprosy Programme introduced
Xpert MTB/RIF in 2012 at two regional hospitals for evaluation of the technique. In 2013
Xpert MTB/RIF was installed in thirteen health facilities but without standard guidelines or an
algorithm from the TB Programme.
The main purpose of the routine surveillance system in Tanzania is to monitor the TB Pro-
gramme at the district, regional and national levels. This includes identifying individuals with
drug resistance and informing the districts, so they can be put the patient on appropriate
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treatment as early as possible. The current Routine Surveillance System requires, morning
specimens from 25% of new cases and 100% of previously treated cases to be routinely col-
lected at the peripheral level and, sent to the Central TB Reference Laboratory in Dar es Salaam
from the districts and regions. Transportation uses public transport or Expedited Mail Services
(EMS). [9]. This study focuses on the previously treated cases because that is where most
MDR-TB cases are found. [6,10], although lessons learnt for previously treated cases are also
likely to be relevant to new TB cases. In addition, failure to appropriately track these cases
could lead to emergence of XDR-TB in the country, so understanding whether (and if not–
why not?) drug susceptibility testing was taking place for all previously treated cases was con-
sidered critical. Effective specimen shipment arrangements are essential to ensuring all speci-
mens are received and tested at the reference laboratory. In addition, transportation can effect
specimen viability, speed of results feedback and therefore the quality of patient management.
Previously treated TB cases submit specimens throughout the year to the Central Reference
Laboratory. Results are sent back to Regional TB Coordinators who then distribute them to
the requesting site.
The study noted that, since the TB Programme’s inception in 1977 there has never been any
systematic evaluation of the routine surveillance system. A study is therefore much needed to
identify the system’s pitfalls and develop interventions that could lead to improved identifica-
tion of drug resistance and to avert the spread of drug resistant TB.
Objectives of the study
The main objective of this study was to explore the effectiveness and stakeholder perception of
the current routine surveillance system for previously treated tuberculosis cases in Tanzania
with a view to identifying interventions to improve and accelerate positive patient outcomes.
Methods
Study sites
The quantitative part of the study reviewed the country routine TB laboratory data collected
electronically from TB laboratory registers at the Central TB Reference Laboratory from Janu-
ary 2011 to December 2013. The dataset contained information on all the specimens received
at the Central TB Reference Laboratory from across the country. [9].
The information from the quantative part of the study fed into the design of the qualitative
part of the study which covered four regions purposely selected with the highest levels of noti-
fied TB cases in Tanzania in the year 2012. [11]. The regions were Dar es Salaam (21.9% of all
cases in Tanzania), Arusha (4.9%), Morogoro (5.1%) and Shinyanga (6.4%). [11].
Study design. A cross-sectional study that employed both quantitative and qualitative
data collection was conducted. The quantitative approach was used to analyse routine data col-
lected from January 2011 to December 2013 to understand the volumes, timings and results
from the current routine surveillance system (RSS). A qualitative approach was used to seek to
understand from stakeholders working in the programme and involved in the RSS how they
perceived the current RSS in order to understand its strengths, weaknesses and how it might
be improved from their perspective.
The quantitative data collected included information on completion of request forms, tran-
sit times, turnaround time, culture positivity and contamination rates. The transit time is the
time between sputum collection at the peripheral site and the specimen receipt at the Central
TB Reference Laboratory. According to the National TB and Leprosy Program the anticipated
transit time should be a maximum of 7 days. [9]. Turnaround time is defined as the time be-
tween a specimen arriving at the Central TB Reference Laboratory and results being reported
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back to the requesting facility. [12]. The expected turnaround time for smear microscopy is 1
day, culture is 56 days, and drug susceptibility testing is 42 days. [8].
The qualitative data collection focused on stakeholders purposely sampled including members
of the health system staff at the National TB and Leprosy Programme, the Central TB Reference
Laboratory, and health care workers at regional/district level. Implementing partners supporting
the National TB and Leprosy Programme and Ministry of Health Officials were also included.
Qualitative methods used were in-depth interviews (IDI) and Focus Group Discussions (FGD).
These methods gave maximum opportunity for different perspectives from diverse groups to
be gathered and ensured the findings would be broad and representative. Oral and written expla-
nations of the aims and expected benefit of the study were provided. All participants willingly par-
ticipated and were made aware of the tape-recording of interviews. The research assistants
emphasised the importance of confidentiality throughout the study.[13] The Principal Investiga-
tor provided training to the research team on how to pose open ended questions and observe non-
verbal communication. All interviews were transcribed from tape recordings and transcriptions
were imported to NVIVO 10 software for analysis. Reports were translated from Swahili into
English. To ensure good quality of the transcriptions, the principal investigator checked 5% of the
transcripts. The interviews were read and re-read to find the key messages from the frequency of
similar responses. Key themes and sub-themes were developed from these messages.
Sample size and sampling procedures. A total of six FGDs were conducted involving 45
participants (25 males and 20 females). 10 participants were interviewed using the IDI (6
males and 4 females). The selection of participants was done purposively for Regional TB
Coordinator as there is only one per region. [14]. District TB Coordinator, TB nurse, courier
person, program staff and TB laboratory person at all levels were conveniently selected.[15].
The Central TB Reference Laboratory had twenty staff, therefore the sampling strategy of
selecting study participants for a small population (i.e. less than fifty) was adopted.[16]. At
each selected study site, members were requested to take part in the FGD, there were at least
six to eight participants in each FGD per region. FGDs were guided by two research assistants,
one leading the discussion and the other observing and writing down main points for each
theme. IDIs were conducted with ministry officials, regional/district administrators and imple-
menting partners supporting the TB Programme.
Data collection. The two local research assistants (one female and one male) involved in
both IDIs and FGDs benefited from three weeks training. Each research assistant alternated
between interviewing the participants and taking notes. The interviews lasted 1–1.5 hours. The
data were collected on paper interview forms, Table 1 for FGD and Table 2 for IDI.
To maintain participant’s confidentiality, participant’s names were not captured during the
entire study, instead study numbers; group numbers; and district/region codes were used. As
the principal investigator is currently responsible for overseeing the entire TB laboratory ser-
vices in the country it was felt that using a research assistant would ensure participants were
comfortable in answering the questions honestly. The interviews utilised key themes such as:
Effectiveness and perception of the TB program; routine surveillance system implementation
in Tanzania; Diagnostic method and Centralization of TB Laboratory services; Communica-
tion between the Central TB Reference Laboratory and the districts.
Data analysis.
Quantitative data: Quantitative data were extracted from the routine database at the Central
TB Reference Laboratory and TB laboratory registers covering the three-year period. The col-
lected data were cleaned and analysed using Statistical Package for Social Science (SPSS) version
23. Frequency tables were generated to explore outliers and abnormal values which were then rec-
tified using the available source documents. The transit time (time from specimen collection from
the health facility to the time the specimen was received at the Central TB Reference Laboratory)
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and the turnaround time for TB tests performed at the laboratory were calculated. The proportion
of the specimens tested within the recommended time [17,18] was also calculated and coded as 1,
and those outside this time coded 0. Then descriptive analysis was performed on the proportional
of specimens recorded as out of recommended time.
Qualitative data: Data from the IDI and FGD were analysed using the framework
approach. [19]. Manual analysis began by preparing daily summaries after FGDs. The tape
recorded FGDs were transcribed verbatim in Swahili by a transcriber. Each transcribed FGDs
were reviewed for accuracy by replaying each recorded interview whilst reading and translat-
ing the transcripts. Thereafter, thematic analysis was carried out by assigning data into relevant
themes in order to generate information on study objectives. All transcripts were imported
and analysis using NVIVO 10 for the sixteen IDI and six FGDs. The research team developed
a preliminary thematic framework which was used to code the transcripts. As new themes
emerged from the transcribed data the framework was updated. The analysis came to an end
once the theoretical saturation point had been reached. [13].
Table 1. Topic guide for focus group discussion.
S/
N
TB routine surveillance system Specimen
Transportation
Central TB Reference
Laboratory
Relationship to the
workload
Knowledge on TB Concluding the
discussion
1 How are TB health care workers
involved in the routine
surveillance system?
Does the clinic
transport specimens
to another laboratory?
What is the perception
of the health care
workers on the TB
reference laboratory?
Where do your patients
come from?
How do health care
workers become aware of
new TB diagnostic
strategies?
Is there anything
else you think
would be useful for
the programme to
know?
2 Probe; what is their roles in RSS,
what do they think of the
current method, what is their
perception on the TB
Programme and the reference
laboratory?).
Who does the
specimen
transportation?
(Probe; how is it
transported?)
What do they think
could be done better
or could be sustained?
probe; (how many patients
per day per clinic, if heavy
clinic, why, issues around
health education and who
does the TB screening)
(Probe; from the
programme, training,
internet, collaboration
with the TB programme,
how is it disseminated)
Do you have any
questions about any
aspect of this
interview?
3 Describe how routine
surveillance system is
implemented in your health
facility?
Probe means of
specimen
transportation
(Probe: Issues around
TB networking, results
turnaround time and
the performance).
What perceptions do the
health workers have
towards patient
management?
What do health care
workers know about TB
transmission?
4 Probe; if health care workers
know about the routine
surveillance system and what
type of specimens need to be
sent, algorithm and safety)
(Probe; compared to the
number of staff, skills,
motivation)
Probing on ways it is
transmitted, ways it is
prevented, explore
questions relating to TB
diagnosis)
5 What do health care workers
think are the challenges in
implementing the routine
surveillance system?
What knowledge do the
health care workers have
on RSS?
6 Probe issues related to: causes
that contribute to TB diagnosis
delays, is it the patients or the
programme, feedback of the
results, specimen handling and
support from the TB
Programme).
Probe; how it works,
collaboration with the
reference lab, specimen
to be transported,
frequency)
7 What could be done differently
to make it better, what could be
beneficial to the community?
Key: TB- Tuberculosis; RSS–Routine surveillance system
https://doi.org/10.1371/journal.pone.0212421.t001
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Ethical clearance
Ethical clearance was granted by the Liverpool School and Tropical Medicine Research Ethical
Committee in the United Kingdom and the National Health Research Ethical Review Commit-
tee from National Institute for Medical Research in Tanzania. The Principal investigator sought
permission from the National TB and Leprosy Programme and Regional Administrative
Authorities to conduct the study. Permission was granted by both establishments. Each partici-
pant gave a written consent prior to taking part in the study. Participants were made aware that,
they are free to withdraw from the study at any time, without prejudice. Confidentiality was
maintained throughout the study. They were also informed that, recorded interviews would be
kept up to seven years with their permission. During the interview, simple structured open-
ended questions were used through guidance notes and topic guides. In addition, for the quanti-
tative part the principle investigator obtained permission from the National TB and Leprosy
Programme to use the routine laboratory data from the Central TB Reference Laboratory.
Results: Quantitative findings
Distribution pattern of specimens
The quantitative part of the study analysed routine specimens received at the Central TB Refer-
ence Laboratory during the time under review (2011–2013). There were 16,423 specimens in
total including both new and previously treated TB cases. Of these 2,750 (16.7%) were from
previously treated TB cases which was the focus of this study. The majority of these specimens
(61.7%) were received in 2013 and most were from males (60.2%). (Table 3). 1,495(54.4%)
were from the young adult’ population aged between 25 and 44 years. HIV status was known
in 1,962 (71.4%) and of these 1,293 (65.9%) were HIV negative. A high proportion of speci-
mens 1,118(40.7%) were from the Eastern Zone (Mtwara, Lindi, Dar es Salaam). A total of 98
(3.6%) were recorded as contaminated. (Table 3).
Relation between cases notified versus specimens received
Analysis of the data showed that, out of 8,482 previously treated cases notified across the
country for the three years, only 2,750 (32.4%) were received at the Central TB Reference Lab-
oratory. A significant variation was recorded in 2011 where 2,936 cases were notified and only
Table 2. Topic guide for In-depth interview.
S/
N
Heath workers Views and
Roles
Health workers perception Knowledge on RSS Perceptron on the
Network
Closing
1 What are your views about the
TB control Programme
performance?
Ask for their perspective; is there
anything, which would prevent them
from changing the current services
provided or the system?
What do you know about
TB routine surveillance
system?
Probe what is their
perception of the TB
networking?
Is there anything else you think would
be useful for programme to know? Do
you have any questions about any
aspect of this interview?
2 What do you regard as the
successes of routine
surveillance system?
What have been some of the
challenges for you as an individual?
What recommendation
would you make on RSS?
Any other
comments please?
3 How do you view your own
role in the TB programme?
(Probe)
4 How do you see your role in
supporting TB programme
policies implementation?
Key: TB- Tuberculosis; RSS–Routine surveillance system
https://doi.org/10.1371/journal.pone.0212421.t002
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80(2.7%) were received at the Central TB Reference Laboratory. The trend improved 2013
whereby 2,780 cases notified and 1,697 (61.0%) specimens received at the Central TB Refer-
ence Laboratory. (Fig 1).
Transit Time (Time between sputum collection and arrival at Central TB Reference
Laboratory)
The study findings showed that, 2,608 (94.8%) of previously treated case specimens had
documented transit times. The mean and median transit time was 8.1 and 6(IQR; 0–68)
respectively with a full range of 0 to 100 days. The mean and median transit time was lower 6.1
Table 3. Previously treated TB cases specimens’ received at the Central TB Reference Laboratory from 2011 to 2013.
Variable 2011; N = 80 % 2012; N = 973 % 2013; N = 1,697 % Total %
Zone
Northern 37 46.3 186 19.1 630 37 853 31.0
Southern 3 3.8 115 11.8 94 5.5 212 7.7
Eastern 23 28.8 459 47.2 636 38 1,118 40.7
Lake/Central 17 21.3 210 21.6 315 19 542 19.7
Zone unknown 0 0 3 0.3 22 1.3 25 0.9
Gender
Male 51 63.8 468 48.1 1,137 67 1,656 60.2
Female 29 36.3 319 32.8 550 32 898 32.7
Gender unknown 0 0 186 19.1 10 0.6 196 7.1
Age group
<15 2 2.5 10 1 29 1.7 41 1.5
15–24 8 10 137 14.1 262 15 407 14.8
25–34 21 26.3 294 30.2 444 26 759 27.6
35–44 21 26.3 255 26.2 460 27 736 26.8
45–54 24 30 277 28.5 502 30 803 29.2
Age unknown 4 5 0 0 0 0 4 0.1
HIV status
Positive 14 17.5 206 21.2 449 27 669 24.3
Negative 13 16.3 443 45.5 837 49 1,293 47.0
HIV Unknown 53 66.3 324 33.3 411 24 788 28.7
TB type
Pulmonary TB negative 0 0 4 0.4 1 0.1 5 0.2
Pulmonary TB positive 67 83.8 957 98.4 1,685 99 2,709 98.5
Extra pulmonary TB 2 2.5 3 0.3 1 0.1 6 0.2
TB type not specified 11 13.8 9 0.9 10 0.6 30 1.1
Smear result
Positive 36 45 645 66.3 993 59 1,674 60.9
Negative 44 55 328 33.7 704 42 1,076 39.1
Culture result
Positive 34 42.5 392 40.3 755 45 1,181 42.9
Negative 45 56.3 532 54.7 879 52 1,451 52.8
Contamination 1 1.3 44 4.5 53 3.1 98 3.6
Result not documented 0 0 5 0.5 10 0.6 20 0.7
Keys: HIV- Human Immunodeficiency Virus; N- Number; TB- Tuberculosis.
Zones are Eastern (Mtwara, Lindi, Dar es Salaam); Northern (Arusha, Kilimanjaro, Tanga, Manyara); Southern (Iringa, Mbeya, Ruvuma, Katavi) Central (Dodoma,
Morogoro, Singida) and Lake (Mwanza, Shinyanga, Tabora, Kagera, Kigoma, Geita)
https://doi.org/10.1371/journal.pone.0212421.t003
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and 3(IQR; 1–6.6) in 2011 compared to 2012 and 2013, though the different between the years
was not statistically significant (P = 0.271). (Table 4).
Turnaround Time (Time between specimen arrival at Central Reference Laboratory and
results feedback)
Findings presented from the total 2,750 previously treated TB cases specimens received: Speci-
mens documented and processed within the recommended turnaround time were 1,024(82.3%)
for microscopy; 146(42.4%) for culture and 11(2.8%) for drug susceptibility testing. (Table 5).
The study findings showed that, from the previously treated TB case specimens analysed
(2,750), only1,181(42.9%) were culture positive. From the positive cultures only 392 (33.2%)
were set up for drug susceptibility testing and out of those 373(95.1%) obtained drug suscepti-
bility testing results. Of those 269 (72.1%) were susceptible to all first line anti TB drugs. 72
(19.3%) were MDR-TB, 27(7.2%) were mono-resistant and the remaining 5(1.3%) had other
patterns of resistance. (Table 6).
The qualitative findings
The key themes and sub-themes from the IDI and FGD’s are described below alongside exam-
ple quotes from participants in the interviews and discussions.
Effectiveness of the TB Programme
The findings explored how the routine surveillance system was understood by stakeholders. It
was observed that, some aspects such as support to the districts and the use of the EMS for
transportation of samples was helpful if sustained. Policy makers were said to be good in the
Fig 1. Previously treated cases notified versus specimen received at the Central TB Reference Laboratory– 2011 to
2013.
https://doi.org/10.1371/journal.pone.0212421.g001
Table 4. Transit time for previously treated cases from 2011 to 2013.
Year Number Mean transit time Standard Deviation Median transit time p25 p75 F-value p-value
2011 76 6.1 6.9 3 1 6.5 1.3 0.271
2012 911 8.4 12.2 6 4 9
2013 1621 8.1 11.7 5 3 9
Total 2,608 7.7 8.4 6 3 9
Keys: p25- is the 25th percentile (1st quartile); p75- is the 75th percentile (3rd quartile).
https://doi.org/10.1371/journal.pone.0212421.t004
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FGD’s. However, some aspects such as staff demotivation, failure to follow good practices,
delayed test results and a lack of rapid diagnostic technology were also noted.
The following quote illustrates: “I think to be very sincere; the support they are giving us at
peripheral level is tremendous. They are supportive and as far as the National TB and Leprosy
Programme is concerned and very well organized, when we have a problem they will sort it
out” (FGD –2014)”.
Routine surveillance system implementation in Tanzania
The routine surveillance system in Tanzania is a system where specimens are collected rou-
tinely and sent to the Central TB Reference Laboratory via EMS for additional testing (culture
and drug susceptibility testing). The purpose is to identify drug resistant patients, so they can
start treatment as early as possible. During FGD some males and two females suggested that
the routine surveillance system needs improvement.
Table 5. Turnaround time for previously treated cases’ specimens from 2011 to 2013.
S/N Status Microscopy Culture Drug susceptibility testing
1 Within recommended time 1,024(82.3%) 1,146(42.4%) 11(2.8%)
2 Out of recommended time 220(17.7%) 1,557(57.6%) 381(97.2%)
Total 1,244 2,703 392
https://doi.org/10.1371/journal.pone.0212421.t005
Table 6. Drug susceptibility testing results profile from 2011–2013.
Year 2011 2012 2013 Total % of Total
Positive Culture 34 392 755 1,181 100
DST Not Done 6 235 548 789 66.8
Total number set up for DST 28 157 207 392 33.2
Total number with DST results 28 151 194.0 373 31.6
Total number DST contaminated 0 6 13 19 1.6
DST Patterns % of Results
Total Susceptible to all 16 123 130 269 72.1
Total MDR TB 9 16 47 72 19.3
Total Mono resistant 3 12 12 27 7.2
Total other resistant 0 0 5 5 1.3
MDR TB
HRES 5 8 18 31 8.3
HRS 4 1 14 19 5.1
HR 1 7 14 22 5.9
Mono resistant
H 1 5 2 8 2.1
S 1 1 3 5 1.3
R 1 6 7 14 3.8
Other resistant
HS 0 0 4 4 1.1
ES 0 0 1 1 0.3
DST- drug susceptibility testing; MDR- multidrug resistant tuberculosis; TB- tuberculosis; HSRE; H-Isoniazid; R- Rifampicin; S-Streptomycin; E-Ethambutol.
https://doi.org/10.1371/journal.pone.0212421.t006
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The following quote illustrates; “Despite Routine Surveillance is working well, the way I see
most of its targets have not reached, I suggest that it is better if the number of people responsi-
ble should circulate the information to all health care providers on how to do it for better
understanding.” (FGD-2014).
“Another challenges I have seen so far, is transportation is also quite a big challenge. Different
areas, can be difficult to get specimens to reach the central level quick enough and the methods
used to examine the specimens like the Lowenstein Jensen medium taking too long to get
results and request forms not filled in properly”(FGD-2014).
Poor supervision was associated with staff demotivation.
The following quote illustrates; “there is a need to strengthen supervision, make it more fruit-
ful not just a vehicle visiting. It needs to be supportive, get there, stay with the staff, for them
to recognize and listen to their problems and establish the hidden problems too then provide
solution” (IDI– 2014).
“If the supervision is done properly it will discover many things and resolve problems.”
(FGD_2014)
A male stakeholder said that, training was important in order to be up to date.
As the quote below illustrate; “Education is not only done once, it is a continuous process, and
people need to be taught regularly, provide people new techniques or to refresh them.”
(IDI_2014).
Staff revealed that there are frequent stock outs of supplies.
The following quote from a female member of staff illustrates; “Another challenge is sometimes
there is lack or shortage of packaging materials and supplies, we used to receive these items
from donor but their contract finished, this is now a problem. We need to know how to pack-
age specimens in layers to avoid leakages and specimen rejections at the Central TB Reference
Laboratory” (IDI-2014)
Due to failure to follow good practices, issues such as preparation of specimen packaging
and form filling were among the things raised in interviews by two males.
The following quote illustrates; “This is a long-standing problem laboratory request forms not
filled in well, a lot of information is missing. We see forms coming with either one name or
just initials and the rest of the information not filled in”. (FGD_2014).
Both male and female participants in FGD observed that in some districts, sputum speci-
mens are sometimes delayed or interrupted this could be due to lack of funds for
transportation.
The following quotes illustrate; “In a parcel of specimens, you could find one specimen 15 days
old and another 3 days old, something impossible. I think they get a specimen but they don’t
send it on time. Instead they wait for them to be many before sending. (FGD_2014).
We have a challenge on how to send those specimens. Who will take the specimens to the sta-
tions and who will pick the specimens up in Dar es Salaam and who will pay the costs for
Routine surveillance for control of tuberculosis drug resistance in Tanzania
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sending specimens? We had a partner but their contract ended. So, that is still hanging in the
air waiting for someone else to kick in.” (IDI_ 2014).
A few male TB staff felt Dar es Salaam is less impacted compared to other regions.
The following quotes illustrate; “the transportation from Dar es Salaam Laboratory to the
Central TB Reference Laboratory is not a problem, they can use bodaboda or EMS. Actually
biggest problem is referring samples from peripheral laboratory to district laboratory where
post services is not available;(IDI_2014).
During the FGD three males commented that there was no standard guideline for specimen
referral or schedule for shipment.
The following quotes illustrate; “First of all coordinators need to know the time specimen are
to be sent to Dar es Salaam for culture, the awareness of the importance of those specimens
should be there so that they would have enough containers and be able to truck the specimens
as they are sent by EMS.” (FGD_2014).
Diagnostic method and centralization of TB laboratory services
Some of the respondents asserted that, contamination problems lead to tests being repeated
and there is a need to inform the clinicians about the duration and methods used.
The following quote illustrates; “I think sometimes they are late as mentioned, there are many
challenges, some examinations, whose specimen has spoilt(contaminated) that needs to be re-
tested and that is when they are delayed and not intentionally” (IDI-2014).
Some felt that, there is a need to use rapid method for early diagnosis and patient
management.
The following quotes illustrates; “I would say the methods used to examine the specimens like
the LJ medium method for culture and the drug susceptibility testing both take too long. I
think it is a big challenge because we need to be able to get these results quicker, for instance,
they could be examined by liquid culture and drug susceptibility testing is done using molecu-
lar methods these could give results quicker”. (IDI-2014).
Another quote illustrates the problems of current diagnostic tools taking too long; “But
another challenge is the delay in results, but I think the patients and the clinicians are not get-
ting the right message. They think culture and drug susceptibility testing would only be a day’s
work, which is not right culture on its own takes up to eight weeks” (IDI, FGD-2014).
One male coordinator said that the process of centralization of supplies and commodities
may be the cause of result delays.
The following quote illustrates “Our programme is vertical, so when there is a shortage of
slides we grieve, they should integrate so that some of these things could also be budgeted for
by the councils at the district level.” (IDI-2014)”
Some male and female participants said that, Central TB Reference Laboratory staff are
overwhelmed.
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The following quote illustrates; “Central TB Reference Laboratory staff have been trying to
perform their work but they are overloaded with many specimens from each side of the coun-
try. One reference laboratory for culture and drug susceptibility testing in Tanzania, I would
suggest that, to identify another branch to reduce congestions which causes results delays”
(FGD, 2014).
Communication between the Central TB Reference Laboratory and the
districts
Communication between the Central TB Reference Laboratory and the district was mentioned
to be very important to ensure people know what is going on. There is a need to improve com-
munication between Central TB Reference Laboratory and peripheries.
The following quote illustrates; “My perception the networking is not that strong, one reference
laboratory for the whole country without internet and telephone services for sharing informa-
tion.”(IDI-2014).
In addition, it was commented that result dissemination methods were not ideal as results
are first sent to the Regional TB Coordinator and not the original requestors who manage the
patients.
The results from the qualitative research were reviewed and are presented according to the
key themes in Fig 2. The three main health system areas were the District Diagnostic Centres,
transportation between the District Diagnostic Centres and the Central TB Reference Labora-
tory, and the Central TB Reference Laboratory itself. In each of these areas key themes from
the IDI’s and FGD’s were identified and then sometimes further divided into subthemes. Key
themes identified at the District Diagnostic Centres were staff demotivation, failure to follow
good practice, delays sending samples, and lack of appropriate technology. In relation to trans-
portation between the districts and the Central TB Reference Laboratory the key themes were
the unavailability of reliable transportation, funding unavailable for transportation, and the
distance between the districts and the Central TB Reference Laboratory. At the Central TB Ref-
erence Laboratory, the key themes were unreliable diagnostic technology, contaminated sam-
ples, and poor communication with districts. These key themes and related sub-themes are
shown in Fig 2 along with how many of these themes are interconnected.
Discussion
The qualitative part of the study involved FGD’s and IDI’s with key stakeholders in every area
involved in the routine surveillance system. It was designed to try and understand why some
of the shortfalls in performance of the system observed in the quantitative analysis were occur-
ring, and potentially to identify initiatives to address these weaknesses. The study results
showed an association between the quantitative and qualitative results in many areas. For
example, in the quantitative results of this study, it was found that the target of 100% of previ-
ously treated TB cases specimens being routinely investigated for drug resistant at the Central
TB Reference Laboratory was far from being met. Only 61% of cases were sent for testing even
in the best year of the three-year period investigated. This implies cases of drug resistance are
likely to have been missed and full surveillance of the TB programme was not undertaken.
This was also noted in the qualitative findings which showed the system of TB specimen trans-
portation in Tanzania was a major problem in remote health facilities as there were no postal
services and no reliable and frequent means of transport. In addition, this led to specimen
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batching at the district level hence delays in sending samples and diagnosis. This was associ-
ated with lack of funds to transfer specimens timely. This was also seen in the quantitative part
of the study which showed the median transit time from sputum collection to arrival at the
Central TB Reference Laboratory was over 7 days which may also have affected specimen cul-
ture viability. The proportion of samples processed within the recommended turnaround time
at the Central TB Reference Laboratory for microscopy was 82.4%, for culture 42.4% and for
drug susceptibility testing just 2.8%. This implies that more than 50% of the culture processed
specimens and more than 90% of the drug susceptibility testing processed specimens were
unable to get results in a timely. The consequence of this is a delay for patients getting onto
appropriate treatment which in turn is likely to affect patient outcomes. This also correlates
with the qualitative part where results delay was one of the aspects raised in the majority of
interviews with health care workers. The current RSS was seen as poor in relation to the feed-
back and communication of the drug susceptibility testing results from the Central TB Refer-
ence Laboratory to the peripheries.
Fig 2. Key themes and sub-themes. Key: CTRL–Central TB Reference Laboratory. RSS–Routine Surveillance system.
https://doi.org/10.1371/journal.pone.0212421.g002
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The overall turnaround time of drug susceptibility testing results is influenced by many
aspects which include the laboratory procedures, but in Tanzania are also impacted by there
being only one drug susceptibility testing laboratory for the whole country. Park et al [20]
comment that the centralization of drug sensitivity testing has led to overwhelming workload
at the Central TB Reference Laboratory, significantly contributing to ineffectiveness of the sys-
tem in the country. Our study is in line with Harries et al who revealed that, problems often
exist at all stages of the system from specimen transportation, processing and documentation.
[21]. This study also showed the policy of all positive culture slopes to undergo drug suscepti-
bility testing was adhered to in less than 50% of occasions, meaning drug resistant could be
missed Our study is also consistent with Royce et al who noted that, delays due to many “hand-
offs” of specimens through different levels of health system and unintended consequences of
health worker incentive payments can mean even if specimens reach the laboratory they may
not be of adequate quality.[22].
The observed culture contamination rate in our study was 3.6% which was within the rec-
ommended level (0–5%) [3]. However, the Supra National & GLI Mission Visit Report in 2013
showed higher contamination rates (See attached report annex 1). The reason for this differ-
ence was mainly because of the way the contamination rate was calculated in our study which
only considered contaminated if both slopes were contaminated instead of counting each con-
taminated slope. This suggests that the laboratory is probably missing the actual target rate and
that contamination is still a concern.
The observed MDR TB rate of previously treated cases that did receive drug sensitivity test-
ing was surprisingly high (72 out of 373 i.e. 19.3%—see Table 3). WHO estimates for Tanzania
in 2016 were 4.7% of previously treated cases. The reason for this difference is unknown, but
there are three possible explanations. Firstly, that the WHO estimate is an underestimate
which is possible as it is only an estimate and is not based on a recent Drug Resistance Survey
(note: one is currently underway). Secondly, that the observed figure in this study is an overes-
timate, potentially because those cases actually tested are not a random sample of all previously
treated cases. They are potentially the ones that districts are most concerned about and actually
have a higher probability of MDR-TB. The third possible explanation is that samples could
have been contaminated due to the poor functioning of the RSS. Obviously it could be a com-
bination of all three.
Addition qualitative observations from our study were comments on poor communication
between the Central TB Reference Laboratory, weak supervision that contributed to low staff
demotivation, request forms not being checked prior to specimen transportation and a general
failure to follow good practices. These and the other key themes have been mapped in Fig 2.
The study was not without limitations; firstly, the routine data captured electronically was
incomplete due to poor form filling that led to some difficulties in analysing information. It
can be seen that the number of previously treated specimens recorded increased over the three
years of our analysis, but the number received even in the peak was still low compared to the
notified cases. There was a sharp decrease in the number of specimens received in 2011 and
this was due to poor data quality. Secondly, in the qualitative study many of the experienced
laboratory staff were not available for key informant interviews as a result of high staff turn-
over. The initial sampling of personnel for FGDs assumed achieving appropriate number of
participants. [19]. In most of the selected districts the number were less than recommended
resulting in exclusion of some sites. Time for the key informant interviews was limited due to
their tight schedules and therefore some interviews were unavoidably hurried.
The findings of this study could assist the NTLP in its operational plans and funding alloca-
tions. Potential interventions that could be considered are to establish national guidelines for
specimen packaging and referral arrangements to counteract contamination effects; increased
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awareness among district coordinators on the importance of sending specimens within the
recommended period, decentralization of culture and drug susceptibility testing services and
roll out more appropriate rapid TB laboratory techniques such as Xpert MTB/RIF. [23].
Conclusions
The study findings provide a basis for identifying potential methods of improving the routine
surveillance system and thereby providing more timely and appropriate management particu-
larly for patients with MDR-TB. Based on these findings there is a need to address the identi-
fied shortfalls of the current system. The next step would be to pilot a revised a routine
surveillance system that addresses some of these constraints and takes on board the use of
Xpert MTB/RIF at some district diagnostic centres and the Central TB reference Laboratory
with the focus on providing complete and timely information for management of previously
treated TB patients.
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